Global Favipiravir Market Research Report 2022 (Status and Outlook)

Report Overview:

Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative.

The Global Favipiravir Market Size was estimated at USD 165.30 million in 2021 and is projected to reach USD 3.00 million by 2028, exhibiting a CAGR of -43.48% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Favipiravir market covering all its essential aspects. This ranges from a macro-overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Favipiravir Market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Favipiravir market in any manner.

Global Favipiravir Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

ChemRar Group

Glenmark

Fujifilm

Dr. Reddy

R-Pharma

Cipla

Lupin

Sun Pharma

Hisun Pharm

Market Segmentation (by Type)

Brand Drug

Generic Drug

Market Segmentation (by Application)

Influenza Viruses

COVID-19

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study

• Neutral perspective on the market performance

• Recent industry trends and developments

• Competitive landscape & strategies of key players

• Potential & niche segments and regions exhibiting promising growth covered

• Historical, current, and projected market size, in terms of value

• In-depth analysis of the Biobased Transformer Oil Market

• Overview of the regional outlook of the Biobased Transformer Oil Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

• This enables you to anticipate market changes to remain ahead of your competitors

• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

• Provision of market value (USD Billion) data for each segment and sub-segment

• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

• Provides insight into the market through Value Chain

• Market dynamics scenario, along with growth opportunities of the market in the years to come

• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

TABLE OF CONTENTS

1 Research Methodology and Statistical Scope

1.1 Market Definition and Statistical Scope of Favipiravir

1.2 Key Market Segments

1.2.1 Favipiravir Segment by Type

1.2.2 Favipiravir Segment by Application

1.3 Methodology & Sources of Information

1.3.1 Research Methodology

1.3.2 Research Process

1.3.3 Market Breakdown and Data Triangulation

1.3.4 Base Year

1.3.5 Report Assumptions & Caveats

2 Favipiravir Market Overview

2.1 Global Market Overview

2.1.1 Global Favipiravir Market Size (M USD) Estimates and Forecasts (2017-2028)

2.1.2 Global Favipiravir Sales Estimates and Forecasts (2017-2028)

2.2 Market Segment Executive Summary

2.3 Global Market Size by Region

3 Favipiravir Market Competitive Landscape

3.1 Global Favipiravir Sales by Manufacturers (2017-2022)

3.2 Global Favipiravir Revenue Market Share by Manufacturers (2017-2022)

3.3 Favipiravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4 Global Favipiravir Average Price by Manufacturers (2017-2022)

3.5 Manufacturers Favipiravir Sales Sites, Area Served, Product Type

3.6 Favipiravir Market Competitive Situation and Trends

3.6.1 Favipiravir Market Concentration Rate

3.6.2 Global 5 and 10 Largest Favipiravir Players Market Share by Revenue

3.6.3 Mergers & Acquisitions, Expansion

4 Favipiravir Industry Chain Analysis

4.1 Favipiravir Industry Chain Analysis

4.2 Market Overview and Market Concentration Analysis of Key Raw Materials

4.3 Midstream Market Analysis

4.4 Downstream Customer Analysis

5 The Development and Dynamics of Favipiravir Market

5.1 Key Development Trends

5.2 Driving Factors

5.3 Market Challenges

5.4 Market Restraints

5.5 Industry News

5.5.1 New Product Developments

5.5.2 Mergers & Acquisitions

5.5.3 Expansions

5.5.4 Collaboration/Supply Contracts

5.6 Industry Policies

6 Favipiravir Market Segmentation by Type

6.1 Evaluation Matrix of Segment Market Development Potential (Type)

6.2 Global Favipiravir Sales Market Share by Type (2017-2022)

6.3 Global Favipiravir Market Size Market Share by Type (2017-2022)

6.4 Global Favipiravir Price by Type (2017-2022)

7 Favipiravir Market Segmentation by Application

7.1 Evaluation Matrix of Segment Market Development Potential (Application)

7.2 Global Favipiravir Market Sales by Application (2017-2022)

7.3 Global Favipiravir Market Size (M USD) by Application (2017-2022)

7.4 Global Favipiravir Sales Growth Rate by Application (2017-2022)

8 Favipiravir Market Segmentation by Region

8.1 Global Favipiravir Sales by Region

8.1.1 Global Favipiravir Sales by Region

8.1.2 Global Favipiravir Sales Market Share by Region

8.2 North America

8.2.1 North America Favipiravir Sales by Country

8.2.2 U.S.

8.2.3 Canada

8.2.4 Mexico

8.3 Europe

8.3.1 Europe Favipiravir Sales by Country

8.3.2 Germany

8.3.3 France

8.3.4 U.K.

8.3.5 Italy

8.3.6 Russia

8.4 Asia Pacific

8.4.1 Asia Pacific Favipiravir Sales by Region

8.4.2 China

8.4.3 Japan

8.4.4 South Korea

8.4.5 India

8.4.6 Southeast Asia

8.5 South America

8.5.1 South America Favipiravir Sales by Country

8.5.2 Brazil

8.5.3 Argentina

8.5.4 Columbia

8.6 Middle East and Africa

8.6.1 Middle East and Africa Favipiravir Sales by Region

8.6.2 Saudi Arabia

8.6.3 UAE

8.6.4 Egypt

8.6.5 Nigeria

8.6.6 South Africa

9 Key Companies Profiled

9.1 ChemRar Group

9.1.1 ChemRar Group Favipiravir Basic Information

9.1.2 ChemRar Group Favipiravir Product Overview

9.1.3 ChemRar Group Favipiravir Product Market Performance

9.1.4 ChemRar Group Business Overview

9.1.5 ChemRar Group Favipiravir SWOT Analysis

9.1.6 ChemRar Group Recent Developments

9.2 Glenmark

9.2.1 Glenmark Favipiravir Basic Information

9.2.2 Glenmark Favipiravir Product Overview

9.2.3 Glenmark Favipiravir Product Market Performance

9.2.4 Glenmark Business Overview

9.2.5 Glenmark Favipiravir SWOT Analysis

9.2.6 Glenmark Recent Developments

9.3 Fujifilm

9.3.1 Fujifilm Favipiravir Basic Information

9.3.2 Fujifilm Favipiravir Product Overview

9.3.3 Fujifilm Favipiravir Product Market Performance

9.3.4 Fujifilm Business Overview

9.3.5 Fujifilm Favipiravir SWOT Analysis

9.3.6 Fujifilm Recent Developments

9.4 Dr. Reddy

9.4.1 Dr. Reddy Favipiravir Basic Information

9.4.2 Dr. Reddy Favipiravir Product Overview

9.4.3 Dr. Reddy Favipiravir Product Market Performance

9.4.4 Dr. Reddy Business Overview

9.4.5 Dr. Reddy Favipiravir SWOT Analysis

9.4.6 Dr. Reddy Recent Developments

9.5 R-Pharma

9.5.1 R-Pharma Favipiravir Basic Information

9.5.2 R-Pharma Favipiravir Product Overview

9.5.3 R-Pharma Favipiravir Product Market Performance

9.5.4 R-Pharma Business Overview

9.5.5 R-Pharma Favipiravir SWOT Analysis

9.5.6 R-Pharma Recent Developments

9.6 Cipla

9.6.1 Cipla Favipiravir Basic Information

9.6.2 Cipla Favipiravir Product Overview

9.6.3 Cipla Favipiravir Product Market Performance

9.6.4 Cipla Business Overview

9.6.5 Cipla Recent Developments

9.7 Lupin

9.7.1 Lupin Favipiravir Basic Information

9.7.2 Lupin Favipiravir Product Overview

9.7.3 Lupin Favipiravir Product Market Performance

9.7.4 Lupin Business Overview

9.7.5 Lupin Recent Developments

9.8 Sun Pharma

9.8.1 Sun Pharma Favipiravir Basic Information

9.8.2 Sun Pharma Favipiravir Product Overview

9.8.3 Sun Pharma Favipiravir Product Market Performance

9.8.4 Sun Pharma Business Overview

9.8.5 Sun Pharma Recent Developments

9.9 Hisun Pharm

9.9.1 Hisun Pharm Favipiravir Basic Information

9.9.2 Hisun Pharm Favipiravir Product Overview

9.9.3 Hisun Pharm Favipiravir Product Market Performance

9.9.4 Hisun Pharm Business Overview

9.9.5 Hisun Pharm Recent Developments

10 Favipiravir Market Forecast by Region

10.1 Global Favipiravir Market Size Forecast

10.2 Global Favipiravir Market Forecast by Region

10.2.1 North America Market Size Forecast by Country

10.2.2 Europe Favipiravir Market Size Forecast by Country

10.2.3 Asia Pacific Favipiravir Market Size Forecast by Region

10.2.4 South America Favipiravir Market Size Forecast by Country

10.2.5 Middle East and Africa Forecasted Consumption of Favipiravir by Country

11 Forecast Market by Type and by Application (2022-2028)

11.1 Global Favipiravir Market Forecast by Type (2022-2028)

11.1.1 Global Forecasted Sales of Favipiravir by Type (2022-2028)

11.1.2 Global Favipiravir Market Size Forecast by Type (2022-2028)

11.1.3 Global Forecasted Price of Favipiravir by Type (2022-2028)

11.2 Global Favipiravir Market Forecast by Application (2022-2028)

11.2.1 Global Favipiravir Sales (K Units) Forecast by Application

11.2.2 Global Favipiravir Market Size (M USD) Forecast by Application (2022-2028)

12 Conclusion and Key Findings

LIST OF TABLES

Table 1. Introduction of the Type

Table 2. Introduction of the Application

Table 3. Market Size (M USD) Segment Executive Summary

Table 4. Favipiravir Market Size (M USD) Comparison by Region (M USD)

Table 5. Global Favipiravir Sales (K Units) by Manufacturers (2017-2022)

Table 6. Global Favipiravir Sales Market Share by Manufacturers (2017-2022)

Table 7. Global Favipiravir Revenue (M USD) by Manufacturers (2017-2022)

Table 8. Global Favipiravir Revenue Share by Manufacturers (2017-2022)

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Favipiravir as of 2021)

Table 10. Global Market Favipiravir Average Price (USD/Unit) of Key Manufacturers (2017-2022)

Table 11. Manufacturers Favipiravir Sales Sites and Area Served

Table 12. Manufacturers Favipiravir Product Type

Table 13. Global Favipiravir Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion Plans

Table 15. Industry Chain Map of Favipiravir

Table 16. Raw Materials

Table 17. Midstream Market Analysis

Table 18. Downstream Customer Analysis

Table 19. Key Development Trends

Table 20. Driving Factors

Table 21. Favipiravir Market Challenges

Table 22. Market Restraints

Table 23. Global Favipiravir Sales by Type (K Units)

Table 24. Global Favipiravir Market Size by Type (M USD)

Table 25. Global Favipiravir Sales (K Units) by Type (2017-2022)

Table 26. Global Favipiravir Sales Market Share by Type (2017-2022)

Table 27. Global Favipiravir Market Size (M USD) by Type (2017-2022)

Table 28. Global Favipiravir Market Size Share by Type (2017-2022)

Table 29. Global Favipiravir Price (USD/Unit) by Type (2017-2022)

Table 30. Global Favipiravir Sales (K Units) by Application

Table 31. Global Favipiravir Market Size by Application

Table 32. Global Favipiravir Sales by Application (2017-2022) & (K Units)

Table 33. Global Favipiravir Sales Market Share by Application (2017-2022)

Table 34. Global Favipiravir Sales by Application (2017-2022) & (M USD)

Table 35. Global Favipiravir Market Share by Application (2017-2022)

Table 36. Global Favipiravir Sales Growth Rate by Application (2017-2022)

Table 37. Global Favipiravir Sales by Region (2017-2022) & (K Units)

Table 38. Global Favipiravir Sales Market Share by Region (2017-2022)

Table 39. North America Favipiravir Sales by Country (2017-2022) & (K Units)

Table 40. Europe Favipiravir Sales by Country (2017-2022) & (K Units)

Table 41. Asia Pacific Favipiravir Sales by Region (2017-2022) & (K Units)

Table 42. South America Favipiravir Sales by Country (2017-2022) & (K Units)

Table 43. Middle East and Africa Favipiravir Sales by Region (2017-2022) & (K Units)

Table 44. ChemRar Group Favipiravir Basic Information

Table 45. ChemRar Group Favipiravir Product Overview

Table 46. ChemRar Group Favipiravir Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 47. ChemRar Group Business Overview

Table 48. ChemRar Group Favipiravir SWOT Analysis

Table 49. ChemRar Group Recent Developments

Table 50. Glenmark Favipiravir Basic Information

Table 51. Glenmark Favipiravir Product Overview

Table 52. Glenmark Favipiravir Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 53. Glenmark Business Overview

Table 54. Glenmark Favipiravir SWOT Analysis

Table 55. Glenmark Recent Developments

Table 56. Fujifilm Favipiravir Basic Information

Table 57. Fujifilm Favipiravir Product Overview

Table 58. Fujifilm Favipiravir Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 59. Fujifilm Business Overview

Table 60. Fujifilm Favipiravir SWOT Analysis

Table 61. Fujifilm Recent Developments

Table 62. Dr. Reddy Favipiravir Basic Information

Table 63. Dr. Reddy Favipiravir Product Overview

Table 64. Dr. Reddy Favipiravir Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 65. Dr. Reddy Business Overview

Table 66. Dr. Reddy Favipiravir SWOT Analysis

Table 67. Dr. Reddy Recent Developments

Table 68. R-Pharma Favipiravir Basic Information

Table 69. R-Pharma Favipiravir Product Overview

Table 70. R-Pharma Favipiravir Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 71. R-Pharma Business Overview

Table 72. R-Pharma Favipiravir SWOT Analysis

Table 73. R-Pharma Recent Developments

Table 74. Cipla Favipiravir Basic Information

Table 75. Cipla Favipiravir Product Overview

Table 76. Cipla Favipiravir Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 77. Cipla Business Overview

Table 78. Cipla Recent Developments

Table 79. Lupin Favipiravir Basic Information

Table 80. Lupin Favipiravir Product Overview

Table 81. Lupin Favipiravir Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 82. Lupin Business Overview

Table 83. Lupin Recent Developments

Table 84. Sun Pharma Favipiravir Basic Information

Table 85. Sun Pharma Favipiravir Product Overview

Table 86. Sun Pharma Favipiravir Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 87. Sun Pharma Business Overview

Table 88. Sun Pharma Recent Developments

Table 89. Hisun Pharm Favipiravir Basic Information

Table 90. Hisun Pharm Favipiravir Product Overview

Table 91. Hisun Pharm Favipiravir Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 92. Hisun Pharm Business Overview

Table 93. Hisun Pharm Recent Developments

Table 94. Global Favipiravir Sales Forecast by Region (K Units)

Table 95. Global Favipiravir Market Size Forecast by Region (M USD)

Table 96. North America Favipiravir Sales Forecast by Country (2022-2028) & (K Units)

Table 97. North America Favipiravir Market Size Forecast by Country (2022-2028) & (M USD)

Table 98. Europe Favipiravir Sales Forecast by Country (2022-2028) & (K Units)

Table 99. Europe Favipiravir Market Size Forecast by Country (2022-2028) & (M USD)

Table 100. Asia Pacific Favipiravir Sales Forecast by Region (2022-2028) & (K Units)

Table 101. Asia Pacific Favipiravir Market Size Forecast by Region (2022-2028) & (M USD)

Table 102. South America Favipiravir Sales Forecast by Country (2022-2028) & (K Units)

Table 103. South America Favipiravir Market Size Forecast by Country (2022-2028) & (M USD)

Table 104. Middle East and Africa Favipiravir Consumption Forecast by Country (2022-2028) & (Units)

Table 105. Middle East and Africa Favipiravir Market Size Forecast by Country (2022-2028) & (M USD)

Table 106. Global Favipiravir Sales Forecast by Type (2022-2028) & (K Units)

Table 107. Global Favipiravir Market Size Forecast by Type (2022-2028) & (M USD)

Table 108. Global Favipiravir Price Forecast by Type (2022-2028) & (USD/Unit)

Table 109. Global Favipiravir Sales (K Units) Forecast by Application (2022-2028)

Table 110. Global Favipiravir Market Size Forecast by Application (2022-2028) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Favipiravir

Figure 2. Data Triangulation

Figure 3. Key Caveats

Figure 4. Global Favipiravir Market Size (M USD), 2017-2028

Figure 5. Global Favipiravir Market Size (M USD) (2017-2028)

Figure 6. Global Favipiravir Sales (K Units) & (2017-2028)

Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 9. Evaluation Matrix of Regional Market Development Potential

Figure 10. Favipiravir Market Size (M USD) by Country (M USD)

Figure 11. Favipiravir Sales Share by Manufacturers in 2020

Figure 12. Global Favipiravir Revenue Share by Manufacturers in 2020

Figure 13. Favipiravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 14. Global Market Favipiravir Average Price (USD/Unit) of Key Manufacturers in 2020

Figure 15. The Global 5 and 10 Largest Players: Market Share by Favipiravir Revenue in 2021

Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 17. Global Favipiravir Market Share by Type

Figure 18. Sales Market Share of Favipiravir by Type (2017-2022)

Figure 19. Sales Market Share of Favipiravir by Type in 2021

Figure 20. Market Size Share of Favipiravir by Type (2017-2022)

Figure 21. Market Size Market Share of Favipiravir by Type in 2020

Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 23. Global Favipiravir Market Share by Application

Figure 24. Global Favipiravir Sales Market Share by Application (2017-2022)

Figure 25. Global Favipiravir Sales Market Share by Application in 2021

Figure 26. Global Favipiravir Market Share by Application (2017-2022)

Figure 27. Global Favipiravir Market Share by Application in 2020

Figure 28. Global Favipiravir Sales Growth Rate by Application (2017-2022)

Figure 29. Global Favipiravir Sales Market Share by Region (2017-2022)

Figure 30. North America Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 31. North America Favipiravir Sales Market Share by Country in 2020

Figure 32. U.S. Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 33. Canada Favipiravir Sales (K Units) and Growth Rate (2017-2022)

Figure 34. Mexico Favipiravir Sales (Units) and Growth Rate (2017-2022)

Figure 35. Europe Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 36. Europe Favipiravir Sales Market Share by Country in 2020

Figure 37. Germany Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 38. France Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 39. U.K. Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 40. Italy Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 41. Russia Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 42. Asia Pacific Favipiravir Sales and Growth Rate (K Units)

Figure 43. Asia Pacific Favipiravir Sales Market Share by Region in 2020

Figure 44. China Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 45. Japan Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 46. South Korea Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 47. India Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 48. Southeast Asia Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 49. South America Favipiravir Sales and Growth Rate (K Units)

Figure 50. South America Favipiravir Sales Market Share by Country in 2020

Figure 51. Brazil Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 52. Argentina Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 53. Columbia Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 54. Middle East and Africa Favipiravir Sales and Growth Rate (K Units)

Figure 55. Middle East and Africa Favipiravir Sales Market Share by Region in 2020

Figure 56. Saudi Arabia Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 57. UAE Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 58. Egypt Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 59. Nigeria Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 60. South Africa Favipiravir Sales and Growth Rate (2017-2022) & (K Units)

Figure 61. Global Favipiravir Sales Forecast by Volume (2017-2028) & (K Units)

Figure 62. Global Favipiravir Market Size Forecast by Value (2017-2028) & (M USD)

Figure 63. Global Favipiravir Sales Market Share Forecast by Type (2022-2028)

Figure 64. Global Favipiravir Market Share Forecast by Type (2022-2028)

Figure 65. Global Favipiravir Sales Forecast by Application (2022-2028)

Figure 66. Global Favipiravir Market Share Forecast by Application (2022-2028)